$0.420
-0.018 (-4.22%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NRSN por análisis de gráficos similares
Alphio's NRSN stock price prediction model matches the current Neurosense Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.42 (-0.47%). The 1-week path is $0.41 (-3.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Neurosense Therapeutics Ltd?
Neurosense Therapeutics Ltd is currently not a strong buy due to its ongoing financial losses and compliance risks, despite some positive catalysts. The current price is $0.42, which is significantly below the analyst's target of $3, indicating potential upside. However, the company reported a net income loss of $2.15 million for Q3 2024, and it faces a Nasdaq compliance warning for trading below $1.00, which poses a risk to its listing status.
NRSN cerró en $0.42 el Friday, tras bajar -4.22%
Neurosense Therapeutics Ltd (NRSN) last closed at $0.4204, losing -4.22%. These facts feed the 1-day and 1-week NRSN price prediction above.
Factores de la previsión
Los factores de la previsión de Neurosense Therapeutics Ltd (NRSN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NRSN, ordenadas por similitud.
Análisis de estacionalidad de NRSN
Historically the probability of a positive August return for NRSN is 30.16%. September offers the highest probability of a positive month at 90.24%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NRSN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $2.45 | $2.46 | $2.78 | +485.94% |
| Sep 2026 | $1.99 | $2.05 | $2.35 | +388.79% |
| Oct 2026 | $1.82 | $1.82 | $2.18 | +333.09% |
| Nov 2026 | $1.69 | $1.82 | $1.94 | +333.09% |
| Dec 2026 | $2.00 | $2.21 | $2.41 | +426.16% |
En 2026, se proyecta que Neurosense Therapeutics Ltd (NRSN) oscile entre $1.69 y $2.78.
Previsión mensual de Neurosense Therapeutics Ltd para 2026
En Aug de 2026, se proyecta que Neurosense Therapeutics Ltd promedie $2.46, con un mínimo de $2.45 y un máximo de $2.78.
En Sep de 2026, se proyecta que Neurosense Therapeutics Ltd promedie $2.05, con un mínimo de $1.99 y un máximo de $2.35.
En Oct de 2026, se proyecta que Neurosense Therapeutics Ltd promedie $1.82, con un mínimo de $1.82 y un máximo de $2.18.
En Nov de 2026, se proyecta que Neurosense Therapeutics Ltd promedie $1.82, con un mínimo de $1.69 y un máximo de $1.94.
En Dec de 2026, se proyecta que Neurosense Therapeutics Ltd promedie $2.21, con un mínimo de $2.00 y un máximo de $2.41.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.